YD Bio (YDES) Stock Forecast: StockMap's 2-Week Call
YDES stock forecast: StockMap's model makes no two-week call on YD Bio after the Nov 19 close: its evidence is split, 5 reasons for and 10 against. Right in 2 of 4 two-week windows on YDES since Aug 21; by chance, a call on the same dates was right 69% of the time.
YD Bio last closed at $4.56, -5.98% on the session.
Against the IVW growth benchmark the position is -3.65% over the forecast window.
YD Bio's market cap is $323.04M as of November 19, 2026.
No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is 6 (too close to call).
Where YDES sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 5 bullish and 10 bearish.
Agreement across those insights is 33%.
28 daily calls for YDES so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
YD Bio is classified under Health Care / Biotechnology.
StockMap tracks YD Bio as the 200th largest of the 394 companies it covers in the Biotechnology industry, part of the Health Care sector.
Across that group the current two-week reads are 200 Moderate Underperform, 134 Neutral, 43 Strong Underperform and 17 Moderate Outperform.
On that composite YD Bio ranks 50th of 394 in the group, against a group median of -0.27.